One Medical is a membership-based and technology-powered primary care platform with seamless digital health and inviting in-office care, convenient to where people work, shop, live, and click. Its vision is to delight millions of members with better health and better care while reducing costs. Its mission is to transform health care for all through its human-centered, technology-powered model.
Company profile
Ticker
ONEM
Exchange
Website
CEO
Amir Dan Rubin
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
1life Healthcare Inc
SEC CIK
Corporate docs
Subsidiaries
Iora Health, LLC • Iora Senior Health, LLC • Iora Health NE DCE, LLC • Iora Health Quality Network LLC • OM Seniors, Inc. • One Medical ACO, LLC • PeakMed Colorado, LLC ...
IRS number
760707204
ONEM stock data
Latest filings (excl ownership)
15-12G
Securities registration termination
6 Mar 23
EFFECT
Notice of effectiveness
1 Mar 23
POS AM
Prospectus update (post-effective amendment)
22 Feb 23
POSASR
Automatic shelf registration (post-effective amendment)
22 Feb 23
S-8 POS
Registration of securities for employees (post-effective amendment)
22 Feb 23
S-8 POS
Registration of securities for employees (post-effective amendment)
22 Feb 23
S-8 POS
Registration of securities for employees (post-effective amendment)
22 Feb 23
S-8 POS
Registration of securities for employees (post-effective amendment)
22 Feb 23
S-8 POS
Registration of securities for employees (post-effective amendment)
22 Feb 23
8-K
Entry into a Material Definitive Agreement
22 Feb 23
Transcripts
ONEM
Earnings call transcript
2022 Q1
5 May 22
ONEM
Earnings call transcript
2021 Q4
24 Feb 22
ONEM
Earnings call transcript
2021 Q3
4 Nov 21
ONEM
Earnings call transcript
2021 Q2
5 Aug 21
ONEM
Earnings call transcript
2021 Q1
13 May 21
ONEM
Earnings call transcript
2020 Q4
26 Feb 21
ONEM
Earnings call transcript
2020 Q3
10 Nov 20
ONEM
Earnings call transcript
2020 Q2
12 Aug 20
ONEM
Earnings call transcript
2020 Q1
13 May 20
ONEM
Earnings call transcript
2019 Q4
18 Mar 20
Financial summary
| Quarter (USD) | Dec 22 | Sep 22 | Jun 22 | Mar 22 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 223.09 mm | 223.09 mm | 223.09 mm | 223.09 mm | 223.09 mm | 223.09 mm |
| Cash burn (monthly) | (no burn) | 10.25 mm | 38.16 mm | 35.84 mm | 10.71 mm | 17.65 mm |
| Cash used (since last report) | n/a | 220.30 mm | 820.37 mm | 770.52 mm | 230.19 mm | 379.47 mm |
| Cash remaining | n/a | 2.79 mm | -597.28 mm | -547.42 mm | -7.10 mm | -156.38 mm |
| Runway (months of cash) | n/a | 0.3 | -15.7 | -15.3 | -0.7 | -8.9 |
Institutional ownership, Q2 2024
3.3% owned by funds/institutions
| 13F holders | Current |
|---|---|
| Total holders | 1 |
| Opened positions | 0 |
| Closed positions | 0 |
| Increased positions | 0 |
| Reduced positions | 0 |
| 13F shares | Current |
|---|---|
| Total value | 296.04 mm |
| Total shares | 6.78 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| DAG Ventures IV-QP | 6.78 mm | $296.04 mm |
| Proequities | 0.00 | $0.00 |